Golden Biotechnology Corporation (TPEX:4132)
14.95
+0.10 (0.67%)
At close: Feb 26, 2026
Golden Biotechnology Market Cap
Golden Biotechnology has a market cap or net worth of 2.43 billion as of February 27, 2026. Its market cap has decreased by -9.67% in one year.
Market Cap
2.43B
Enterprise Value
2.69B
Revenue
44.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.95
Market Cap Chart
Since May 26, 2010, Golden Biotechnology's market cap has increased from 1.15B to 2.43B, an increase of 111.45%. That is a compound annual growth rate of 4.86%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allied Biotech | 2.39B |
| Johnson Chemical Pharmaceutical Works | 2.55B |
| TSH Biopharm Corporation | 2.12B |
| LIWANLI Innovation | 2.78B |
| PhytoHealth | 2.82B |
| Maywufa Company | 2.92B |
| GeneFerm Biotechnology | 1.79B |
| InnoPharmax | 1.71B |